Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03551925 · ClinicalTrials.gov registry record · NA

Effect of Occupational Therapy in Promoting Medication Adherence

A NA study, sponsored by University of Indianapolis.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT03551925: Completed NA study, sponsored by University of Indianapolis.

NCT03551925 is a NA study that has completed, run by University of Indianapolis. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03551925, a NA study, has completed, sponsored by University of Indianapolis.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The purpose of this research study is to see if an occupational therapist can help people with high blood pressure and/or diabetes find ways to better take their medicine. Participants will be recruited from the Jordan Valley Community Health Center in Springfield, Missouri.

Primary Outcome

The ARMS-7 consists of seven questions that provide a self-report of medication adherence.

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Treatment as Usual Plus Occupational Therapy

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2018-07-01
Est. Completion 2019-06-01
Phase NA
University of Indianapolis

9 total trials

What the finished NCT03551925 record still lists

NCT03551925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT03551925 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03551925 about?

NCT03551925 is a clinical study titled "Effect of Occupational Therapy in Promoting Medication Adherence". The purpose of this research study is to see if an occupational therapist can help people with high blood pressure and/or diabetes find ways to better take their medicine. Participants will be recruited from the Jordan Valley Community Health Center in Springfield, Missouri.

What is the current status of trial NCT03551925?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-07-01. Estimated completion is 2019-06-01.

What interventions are being tested in trial NCT03551925?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Treatment as Usual Plus Occupational Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03551925?

This trial is sponsored by University of Indianapolis, which has 9 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03551925's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03551925, the US trial registry maintained by the National Library of Medicine. NCT03551925 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.